Literature DB >> 19244202

Alterations of the thioredoxin system by hyperoxia: implications for alveolar development.

Trent E Tipple1, Stephen E Welty, Leif D Nelin, Jason M Hansen, Lynette K Rogers.   

Abstract

Alterations in vascular endothelial growth factor (VEGF) contribute to alveolar simplification seen in animal models of bronchopulmonary dysplasia, and VEGF expression is redox regulated by thioredoxin (Trx)-1 in other diseases. The present studies tested the hypothesis that exposure to 85% O2 negatively impacts the Trx1 system and VEGF expression in the lungs of newborn mice. There was no effect of fraction of inspired oxygen on lung Trx1 or Trx reductase-1 protein levels; however, lung Trx1 protein was predominantly oxidized in the lungs of newborn mice exposed to 85% O2 by 24 hours of exposure. In room air (RA), lung Trx interacting protein (Txnip) levels decreased developmentally through Day 7 (1.0 +/- 0.06 [Day 1] vs. 0.49 +/- 0.10 [Day 3] vs. 0.29 +/- 0.03 [Day 7]; P < 0.01), whereas VEGF expression increased (1.25 +/- 0.16 [Day 1] vs. 4.35 +/- 1.51 [Day 3] vs. 13.23 +/- 0.37 [Day 7]; P < 0.01). Newborn mice exposed to 85% O2 had no developmental decrease in Txnip protein levels and a delayed increase in VEGF protein levels. Lung Txnip and VEGF protein levels were different than in corresponding RA controls at Day 3, before the detection of lung morphologic abnormalities in our model. Txnip and VEGF protein levels were inversely correlated in both the RA and hyperoxia-exposed groups (n = 18; R = -0.66; P = 0.003). In conclusion, oxidation of Trx1 and sustained Txnip expression in the lungs of newborn mice exposed to 85% oxygen is likely to severely attenuate normal Trx1 function. The inverse correlation of Txnip with VEGF expression suggests that decreased Trx1 function contributes to the observed lung developmental abnormalities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19244202      PMCID: PMC2778167          DOI: 10.1165/rcmb.2008-0224OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  54 in total

1.  Role of oxygen and vascular development in epithelial branching morphogenesis of the developing mouse lung.

Authors:  Minke van Tuyl; Jason Liu; Jinxia Wang; Maciek Kuliszewski; Dick Tibboel; Martin Post
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-09-17       Impact factor: 5.464

2.  Angiogenic therapy for bronchopulmonary dysplasia: rationale and promise.

Authors:  Kurt R Stenmark; Vivek Balasubramaniam
Journal:  Circulation       Date:  2005-10-18       Impact factor: 29.690

3.  Characterization of the expression of the hypoxia-induced genes neuritin, TXNIP and IGFBP3 in cancer.

Authors:  Sébastien Le Jan; Nolwenn Le Meur; Aurélie Cazes; Josette Philippe; Martine Le Cunff; Jean Léger; Pierre Corvol; Stéphane Germain
Journal:  FEBS Lett       Date:  2006-05-11       Impact factor: 4.124

4.  HIF stabilizing agents: shotgun or scalpel?

Authors:  Tiina M Asikainen; Carl W White
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-07-06       Impact factor: 5.464

5.  Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis.

Authors:  Z Wang; Y P Rong; M H Malone; M C Davis; F Zhong; C W Distelhorst
Journal:  Oncogene       Date:  2006-03-23       Impact factor: 9.867

6.  VDUP1: a potential mediator of expansion-induced lung growth and epithelial cell differentiation in the ovine fetus.

Authors:  C E Filby; S B Hooper; F Sozo; V A Zahra; S J Flecknoe; M J Wallace
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-09-02       Impact factor: 5.464

7.  Hyperoxic ventilated premature baboons have increased p53, oxidant DNA damage and decreased VEGF expression.

Authors:  William M Maniscalco; Richard H Watkins; Jason M Roper; Rhonda Staversky; Michael A O'Reilly
Journal:  Pediatr Res       Date:  2005-09       Impact factor: 3.756

8.  Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats.

Authors:  Anette M Kunig; Vivek Balasubramaniam; Neil E Markham; Danielle Morgan; Greg Montgomery; Theresa R Grover; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-05-20       Impact factor: 5.464

9.  The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange.

Authors:  Parth Patwari; Luke J Higgins; William A Chutkow; Jun Yoshioka; Richard T Lee
Journal:  J Biol Chem       Date:  2006-06-09       Impact factor: 5.157

10.  Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization.

Authors:  Bernard Thébaud; Faruqa Ladha; Evangelos D Michelakis; Monika Sawicka; Gavin Thurston; Farah Eaton; Kyoko Hashimoto; Gwyneth Harry; Alois Haromy; Greg Korbutt; Stephen L Archer
Journal:  Circulation       Date:  2005-10-18       Impact factor: 29.690

View more
  18 in total

1.  A novel mouse model for the identification of thioredoxin-1 protein interactions.

Authors:  Michelle L Booze; Jason M Hansen; Peter F Vitiello
Journal:  Free Radic Biol Med       Date:  2016-09-14       Impact factor: 7.376

2.  Coenzyme Q(1) as a probe for mitochondrial complex I activity in the intact perfused hyperoxia-exposed wild-type and Nqo1-null mouse lung.

Authors:  Robert D Bongard; Charles R Myers; Brian J Lindemer; Shelley Baumgardt; Frank J Gonzalez; Marilyn P Merker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-20       Impact factor: 5.464

3.  Role of glutathione in lung retention of 99mTc-hexamethylpropyleneamine oxime in two unique rat models of hyperoxic lung injury.

Authors:  Said H Audi; David L Roerig; Steven T Haworth; Anne V Clough
Journal:  J Appl Physiol (1985)       Date:  2012-05-24

Review 4.  Role of reactive oxygen species in neonatal pulmonary vascular disease.

Authors:  Stephen Wedgwood; Robin H Steinhorn
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 5.  Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.

Authors:  Samuel Lee; Soo Min Kim; Richard T Lee
Journal:  Antioxid Redox Signal       Date:  2012-06-26       Impact factor: 8.401

6.  Thioredoxin Reductase Inhibition Attenuates Neonatal Hyperoxic Lung Injury and Enhances Nuclear Factor E2-Related Factor 2 Activation.

Authors:  Qian Li; Stephanie B Wall; Changchun Ren; Markus Velten; Cynthia L Hill; Morgan L Locy; Lynette K Rogers; Trent E Tipple
Journal:  Am J Respir Cell Mol Biol       Date:  2016-09       Impact factor: 6.914

7.  Coordinate activation of inflammatory gene networks, alveolar destruction and neonatal death in AKNA deficient mice.

Authors:  Wenbin Ma; Blanca Ortiz-Quintero; Roberto Rangel; Morgan R McKeller; Sara Herrera-Rodriguez; Eliseo F Castillo; Kimberly S Schluns; Mary Hall; Huiyuan Zhang; Woong-Kyung Suh; Hitoshi Okada; Tak W Mak; Yang Zhou; Michael R Blackburn; Hector Martinez-Valdez
Journal:  Cell Res       Date:  2011-05-24       Impact factor: 25.617

Review 8.  The thioredoxin system in neonatal lung disease.

Authors:  Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2014-03-13       Impact factor: 8.401

9.  Thiol-Redox Regulation in Lung Development and Vascular Remodeling.

Authors:  Gaston Ofman; Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2019-03-04       Impact factor: 8.401

10.  99MTc-Hexamethylpropyleneamine Oxime Imaging for Early Detection of Acute Lung Injury in Rats Exposed to Hyperoxia or Lipopolysaccharide Treatment.

Authors:  Said H Audi; Anne V Clough; Steven T Haworth; Meetha Medhora; Mahsa Ranji; John C Densmore; Elizabeth R Jacobs
Journal:  Shock       Date:  2016-10       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.